Hiltzik: This pharma company makes a miracle HIV drug, but is blocking access for millions of low-income people
Business•4/9/2026•business
Gilead's lenacapavir could transform the fight against HIV — but only if millions more patients can get it.
Gilead's lenacapavir could transform the fight against HIV — but only if millions more patients can get it.